However, when using an SEM approach we found little evidence that those who had high depressive
symptom scores at 12 were more likely to experience PEs at 18 if their depressive symptoms had resolved by this age, whereas those with PEs at 12 were slightly more likely to experience depressive symptoms at 18 even if their PEs had resolved by 18 years.
In comparing the patients in initial and follow - up study, the young patients had significantly reduced post-concussion
symptom score at follow - up than at the time of the initial exam, but no significant change of the post-concussion symptom score was observed in the older patients, who also showed persistent hypoactivation.
Not exact matches
«And a good number of them are going to transition into fatherhood so we could actually look
at their depressive
symptoms scores over that time frame.»
Infants would be examined by medical providers
at regular intervals for the presence of atopic dermatitis (using standardized
scoring methods) as well as food allergic
symptoms and other allergic disease (confirmed by IgE testing), and not just the presence of allergic sensitization.
We used the standard Center for Epidemiologic Studies — Depression Scale depressive
symptom score of ≥ 16 to categorize participants as «
at risk» of depression.
«Rather than just looking
at depression as a total
score, we looked
at specific
symptoms such as anxiety.
None of the subjects had full - blown PTSD
at the time of the test; the highest
score on the
symptom scale, 39, was just below the cutoff for a PTSD diagnosis.
At the end of the trial, those who received the high - dose vaccine
scored an average of 39 percent lower on
symptoms and medication use than did those who got the dummy shots.
Of the cheerleaders who denied an increase in concussion
symptoms from baseline, 33 % had
at least one ImPACT
score that exceeded index criteria.
For example, on the Beck Depression Inventory (BDI), a widely used questionnaire in which a
score of 19 or above indicates major depression, women in the study group saw their depressive
symptoms decline from an average of 27
at the beginning of therapy to 9.6 eight months after the program concluded.
The researchers found that HAP participants maintained the benefits they showed
at the end of treatment through the 12 - month period, with significantly lower
symptom severity
scores (adjusted mean difference in BDI - II:?
After analyzing data for numerous variables, including total
score of the PCSS
at initial visit, age, and amnesia
symptoms, only the total
score on the PCSS was independently associated with
symptoms lasting longer than 28 days; the higher the
score, the greater chance of a prolonged recovery time.
Pathology reporting was according to internationally agreed criteria.16 Patient self - reported bladder function and sexual function were measured
at baseline and 6 months following surgery with the International Prostate
Symptom Score (I - PSS), International Index of Erectile Function (IIEF), and Female Sexual Function Index (FSFI).
A genetic
score can help identify infants
at risk of type 1 diabetes before
symptoms develop, according to international scientists.
Notes Dr. Berzin, «
At Parsley, if your
symptom score is 0 and you feel great, we don't recommend taking a probiotic.
At four months» time, she'd lost 30 pounds and her
score on a clinical questionnaire called the PANSS (Positive and Negative
Symptom Scale), which ranks
symptoms on a scale from 30 (best) to 210 (worst), had come down from 107 to 70.
They used two measurements to gauge a drug's effectiveness and tolerability: the percentage of patients who showed
at least a 50 % improvement in their
symptoms as measured by one of two scales, or who
scored «much improved or very much improved» after eight weeks of treatment (or from 6 to 12 weeks if eight - week data wasn't available) and the percentage of patients who dropped out of the study before eight weeks for any reason.
What he realized is that most reform efforts have been directed
at the
symptoms, things like low graduation rates or dismal test
scores.
Elevated
symptom score in the parent rated Symptom Checklist for Oppositional Defiant and Conduct Disorder (FBB - SSV) with Stanine ≥ 7 at pre-ass
symptom score in the parent rated
Symptom Checklist for Oppositional Defiant and Conduct Disorder (FBB - SSV) with Stanine ≥ 7 at pre-ass
Symptom Checklist for Oppositional Defiant and Conduct Disorder (FBB - SSV) with Stanine ≥ 7
at pre-assessment
Our sample can be characterized as high risk (baseline ECBI T
score > 55) 42 or
at the borderline of clinical (T
score > 60), 34 which is typical of previous randomized clinical trials of parent training for young children.41 The results across methods in this study are impressive given that effect sizes have been shown to be associated with the magnitude of
symptom severity
at baseline, 43 and thus it is typically more difficult to find large effects in prevention than in intervention trials.
At 16 weeks, depressive
symptoms were still significantly reduced with IPT - A, but improvements in global functioning were slightly attenuated (mean HAM - D
score: 6.9 v 10.6, p = 0.04, effect size 0.51 (95 % CI 0.003 to 1.02); C - GAS trend to improvement, p = 0.06).
At both baseline and follow - up there was a high rate of depressive
symptoms with one third of the group
scoring 14 or more on the Beck Depression Inventory (a questionnaire designed to measure severity of depressive
symptoms).
Total
scores were dichotomised
at a threshold (
score ≥ 12) to identify
symptoms of depression / anxiety where clinical intervention would be appropriate.24, 25 During adolescence, we identified those with none, one, and two or more waves of depressive
symptoms.
The pre — post effect size (d) was 0.95, and pre — follow - up was 1.08, comparable to effect sizes published investigating face - to - face mindfulness interventions for depressive
symptoms in those with diabetes, PTSD and cancer15, 56, 57 and online cognitive therapy interventions for depressive
symptoms in a moderately depressed sample.27, 36 The change in PHQ - 9 is higher than effect sizes found for IAPT depression and anxiety treatment where follow - up was
at 4 and 8 months (0.46 and 0.63, respectively) 3 where the IAPT sample started with higher baseline depression
scores.
Consistent with previous research by the test developers, 24 we dichotomized infants by a 9 - month ITSC
score of 0 to 2 (no or mild regulatory problems) versus ≥ 3 parent - endorsed
symptoms (moderate to severe regulatory problems), as this threshold has predicted elevated risk of developmental and behavioral problems
at 3 to 4 years of age.25
Categorical outcomes for depression (50 % decrease in depression
scores on
symptom checklist and major depression by structured clinical interview for DSM - IV) since baseline assessment
at three and six month blinded outcome assessments in patients receiving usual care (n = 196), feedback only (n = 221), and care management (n = 196)
At 12 weeks, the intervention group adjusted mean
score for depressive
symptoms on the BDI - II was significantly lower than the control group by 5.8 points (95 % CI − 11.1 to − 0.5) after adjusting for baseline depression
scores, anxiety, sociodemographics, psychotropic medication use and clustering by practice.
Adjusted regression analyses evaluated predictors of prompts, the percentage of assertive prompts, and intrusiveness and the relation of each of these factors with child adiposity (weight - for - length z
score at 15 mo and BMI z
score at 24 and 36 mo) after control for the child's race - ethnicity and sex, family income - to - needs ratio, and maternal education, weight status, and depressive
symptoms.
Scoring programs for the CAPA and YAPA, written in SAS, 41 combined information about the date of onset, duration, and intensity of each
symptom to create diagnoses according to the DSM - IV.29 With the exception of attention - deficit / hyperactivity disorder (ADHD), for which only parental reports were counted, a
symptom was counted as present if it was reported by either the parent or the child until age 16 years or by the young adult
at ages 19 and 21 years, as is standard clinical practice.
For the primary aim, differences in the changes in maternal weight and the EPDS
symptoms score between enrolment after GDM diagnosis and 1 year postpartum
at the end of the study between the intervention and the control group will be analysed using linear regression analysis.
The elevated 30 - month Center for Epidemiological Studies Depression Scale
scores in the intervention group were driven by a higher prevalence of depressive
symptoms among the PP+HS group (a difference not present
at baseline).
The outcomes of interest were depressive
symptom scores and disease remission rates
at the end of treatment.
A high parental
symptom load was defined as having a
score of 8 or above (recommended cut - off value) on
at least one of the subscales (HADS - A and / or HADS - D).19 Three groups were identified according to whether no parent, one parent or both parents had a high anxiety or depression
symptom load.
Many of the scales demonstrated weak psychometrics in
at least one of the following ways: (a) lack of psychometric data [i.e., reliability and / or validity; e.g., HFQ, MASC, PBS, Social Adjustment Scale - Self - Report (SAS - SR) and all perceived self - esteem and self - concept scales], (b) items that fall on more than one subscale (e.g., CBCL - 1991 version), (c) low alpha coefficients (e.g., below.60) for some subscales, which calls into question the utility of using these subscales in research and clinical work (e.g., HFQ, MMPI - A, CBCL - 1991 version, BASC, PSPCSAYC), (d) high correlations between subscales (e.g., PANAS - C), (e) lack of clarity regarding clinically - relevant cut - off
scores, yielding high false positive and false negative rates (e.g., CES - D, CDI) and an inability to distinguish between minor (i.e., subclinical) and major (i.e., clinical) «cases» of a disorder (e.g., depression; CDI, BDI), (f) lack of correspondence between items and DSM criteria (e.g., CBCL - 1991 version, CDI, BDI, CES - D, (g) a factor structure that lacks clarity across studies (e.g., PSPCSAYC, CASI; although the factor structure is often difficult to assess in studies of pediatric populations, given the small sample sizes), (h) low inter-rater reliability for interview and observational methods (e.g., CGAS), (i) low correlations between respondents such as child, parent, teacher [e.g., BASC, PSPCSAYC, CSI, FSSC - R, SCARED, Connors Ratings Scales - Revised (CRS - R)-RSB-, (j) the inclusion of somatic or physical
symptom items on mental health subscales (e.g., CBCL), which is a problem when conducting studies of children with pediatric physical conditions because physical
symptoms may be a feature of the condition rather than an indicator of a mental health problem, (k) high correlations with measures of social desirability, which is particularly problematic for the self - related rating scales and for child - report scales more generally, and (l) content validity problems (e.g., the RCMAS is a measure of anxiety, but contains items that tap mood, attention, peer interactions, and impulsivity).
At the end of treatment, 81 % of those in CBCT had a clinically significant improvement in their PTSD
symptoms and 81 % no longer met criteria for PTSD, which was defined as not meeting DSM - IV - TR
symptom criteria and a total
score lower than 45 on the CAPS.
418 adolescents aged 13 — 21 years, presenting
at clinic with either of two criteria: endorsed «stem items» for major depression or dysthymia from 12 month Composite International Diagnostic Interview (CIDI - 12), one week or more of depressive
symptoms in the past month, and a total Center for Epidemiological Studies Depression Scale (CES - D)
score of ⩾ 16; or a CES - D
score of ⩾ 24.
This pattern of change in means over the decade between the 2005 study and ours appears consistent with the small, but significant, increases observed between 2007 and 2012 in the self - report subscale means for Total Difficulties, Emotional
Symptoms, Peer Relationship Problems and Hyperactivity - Inattention (but a decrease in Conduct Problems) in nationally representative New Zealand samples of children aged 12 — 15 years, 28 and with a similar increase in Emotional
Symptoms and decrease in Conduct Problems between 2009 and 2014 in English community samples of children aged 11 — 13 years.29 The mean PLE
score in the MCS sample aligned closely with that reported previously for a relatively deprived inner - city London, UK, community sample aged 9 — 12 years19 using these same nine items, although the overall prevalence of a «Certainly True» to
at least one of the nine items in the MCS (52.2 %) was lower than that obtained in the London sample (66.0 %).8
At baseline, severe depression (BDI
score ≥ 10) was present in 27 men (14.4 per cent); mild depressive
symptoms (BDI
scores 5 — 9) in 73 (38.8 per cent); and no depression (BDI
score < 5) in 88 men (46.8 per cent).
Results from the longitudinal multivariate analyses, indicated that the
scores for optimism and negative life events were significantly associated with
scores of somatic
symptoms at time - point two (T2).
Symptom severity was assessed
at baseline and annually using the Positive and Negative
Symptom Scale
score.
Total Child PTSD Reaction Index
scores, as well as
scores on two of three
symptom clusters, were significantly reduced
at the posttest.
The purpose of this study was to examine the effects of the Strong African American Families (SAAF) on a subset of 167 families in which the primary caregivers demonstrated elevated levels of depressive
symptoms at pretest as indicated by a
score of 16 or higher on the Center for Epidemiologic Studies — Depression scale (CES — D).
More detailed analysis of movement between normal, borderline and abnormal classifications indicated that 65 % of children with an emotional
symptoms score in the abnormal range
at school entry had
scored in the normal range
at age 3.
For inclusion, adolescents had to
score at least 32 on the APAI (
score range 0 — 105, higher
score indicates greater severity of
symptoms), although 14 adolescents with
scores between 28 and 31 were included to achieve target sample size, and report some difficulties in function on a gender - specific local function measure.
Children in CFF - CBT had more improvement in parent - reported mania
scores, lower parent - rated depression
scores and a steeper response curve for depressive
symptoms at post-treatment and 6 - months (effect sizes of 0.48 — 0.69).
Results indicated that
at the 2 - year follow - up,
scores on the measures of PTSD
symptoms, depression and externalizing behaviors remained comparable to
scores at the original post-treatment assessment.
Scores of 3 to 5 were considered to indicate significant impairment (3, definitely a problem
at times, somewhat of a problem on numerous occasions, with some interference in functioning, or clinically significant distress; 5,
symptom compromises functioning and is a major problem).
Primary outcomes were the Posttraumatic Diagnostic Scale (PDS) 25,26 for PTSD
symptoms and the
Symptom Checklist Depression Scale (SCL - 20) for depressive
symptoms.27 The PDS (17 items) assesses severity of PTSD
symptoms over the prior 4 weeks with high internal consistency and test - retest reliability26;
scores are summed and range from 0 to 51;
scores of 10 or less are mild; 11 to 20, moderate; 21 to 35, moderate to severe; and
at least 36, severe.
We plan to: (a) identify high risk adolescents based on elevated
scores on a screening measure of depressive
symptoms that is delivered in primary care; (b) recruit 400 (200 per site) of these
at - risk adolescents to be randomized into either the CATCH - IT or the Educational group; and (c) assess outcomes
at 2, 6, 12, 18 and 24 months post intake on measures of depressive
symptoms, depressive diagnoses, other mental disorders, and on measures of role impairment in education, quality of life, attainment of educational milestones, and family functioning; and to examine predictors of intervention response, and potential ethnic and cultural differences in intervention response.
Where participants were not diagnosed with anxiety and depression
symptoms at baseline,
scores were compared against...